KANSAS CITY, Mo., and MENLO PARK, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) — Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced a collaboration designed to further understand the most challenging pediatric... Read more
Basel, 15 October 2020 Group sales increase 1%1 at constant exchange rates and decline 5% in Swiss francs as a result of continued appreciation of the Swiss franc against most currencies Impact of COVID-19 pandemic: Following strong sales growth in the first quarter (+7%) and COVID-19 related decline in the second quarter (-4%) sales stabilise... Read more
Basel, 13 October 2020 The Elecsys® SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of SARS-CoV-2 infection This new solution will run on all Roche cobas e immunochemistry analysers which are widely available around the world, thus helping to increase testing capacity In combination with other COVID-19 diagnostic... Read more
Novel use of expansion microscopy with ZEISS Airyscan technology Primary cilia are organelles that protrude from the cell surface and function as “cellular antennae” to receive and transduce extracellular signals. They are approximately 3 µm in length and 0.3 µm in diameter, which is below the optical diffraction limit of standard light microscopes. Junior Associate... Read more
Research highlights use of ZEISS MultiSEM and ZEISS Sigma electron microscopes Globally, macular degeneration of the retina is a leading cause of legal blindness; however, little is known about its cause. A recent article by Dr. Charles Zucker, Staff Scientist at Harvard University, and colleagues describes electron microscopic observations from the retina of a woman... Read more
Hilden, Germany, and Germantown, Maryland, September 08, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to launch a rapid portable test that can detect SARS-CoV-2 antigens in people with active infections in less than 15 minutes and process on average around 30 swab samples per hour using a small digital detection... Read more
Hilden, 8. September 2020 – QIAGEN hat heute angekündigt, mehr als 110 Mio. Euro in den Ausbau seiner Kapazitäten für die Fertigung von COVID-19-Testprodukten an den Standorten Hilden, Germantown (Maryland, USA) und Barcelona zu investieren. Mit dem bislang größten Investitionsprogramm in der Unternehmensgeschichte setzt QIAGEN seine Anstrengungen fort, den globalen Kampf gegen die Pandemie durch die Erhöhung von... Read more
CAMBRIDGE, Inglaterra–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) ha anunciado hoy una colaboración con 54gene, una empresa de tecnología sanitaria cuya misión es hacer avanzar las capacidades de la medicina de precisión en África a través de la investigación, los diagnósticos moleculares avanzados y los programas clínicos. La asociación ayudará a la creación de una nueva instalación... Read more
CAMBRIDGE, England–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) gab heute eine Zusammenarbeit mit 54gene bekannt, einem Unternehmen der Gesundheitstechnologie, dessen Aufgabe es ist, die Fähigkeiten der Präzisionsmedizin in Afrika durch Forschung, fortschrittliche molekulare Diagnostik und klinische Programme zu fördern. Die Partnerschaft wird die Einrichtung einer neuen Genetik-Einrichtung in Lagos, Nigeria, unterstützen, die mit einer Reihe von Illuminas... Read more
CAMBRIDGE, Inghilterra–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) ha annunciato oggi una collaborazione con 54gene, società operante nel campo delle tecnologie sanitarie la cui missione è promuovere le competenze della medicina di precisione in Africa attraverso ricerca, diagnostica molecolare avanzata e programmi clinici. La partnership sosterrà la creazione di un nuovo centro di genetica a Lagos, in... Read more